These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30104400)
1. The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1. Wu H; Wang Y; Chen T; Li Y; Wang H; Zhang L; Chen S; Wang W; Yang Q; Chen C Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30104400 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
4. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960 [TBL] [Abstract][Full Text] [Related]
5. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition. Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992 [TBL] [Abstract][Full Text] [Related]
6. PDK1-stabilized LncRNA SPRY4-IT1 promotes breast cancer progression via activating NF-κB signaling pathway. Zhang Y; Chen H; Yuan R; Wang Y; Zhang D; Zeng Q; Jiang W; Zhang R; Chen T; Chai C; Guo B Mol Carcinog; 2023 Jul; 62(7):1009-1024. PubMed ID: 37042573 [TBL] [Abstract][Full Text] [Related]
7. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2. Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition. Shen F; Cai WS; Feng Z; Chen JW; Feng JH; Liu QC; Fang YP; Li KP; Xiao HQ; Cao J; Xu B Oncotarget; 2017 Feb; 8(9):14479-14486. PubMed ID: 27391336 [TBL] [Abstract][Full Text] [Related]
9. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935 [TBL] [Abstract][Full Text] [Related]
10. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers. Li J; Chen Y; Chen Z; He A; Xie H; Zhang Q; Cai Z; Liu Y; Huang W Tumour Biol; 2017 Jun; 39(6):1010428317711406. PubMed ID: 28651500 [TBL] [Abstract][Full Text] [Related]
11. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression. Shi Y; Li J; Liu Y; Ding J; Fan Y; Tian Y; Wang L; Lian Y; Wang K; Shu Y Mol Cancer; 2015 Feb; 14():51. PubMed ID: 25742952 [TBL] [Abstract][Full Text] [Related]
12. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition. Yu J; Han Q; Cui Y Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition. Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells. Guo W; Zhong K; Wei H; Nie C; Yuan Z PLoS One; 2018; 13(2):e0193483. PubMed ID: 29489909 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SPRY4-IT1 promotes proliferation and invasion by acting as a ceRNA of miR-101-3p in colorectal cancer cells. Jin J; Chu Z; Ma P; Meng Y; Yang Y Tumour Biol; 2017 Jul; 39(7):1010428317716250. PubMed ID: 28720069 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer. Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression. Yang L; Cheng X; Ge N; Guo W; Feng F; Wan F Oncotarget; 2017 Jan; 8(2):3104-3110. PubMed ID: 27902971 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer. Peng W; Wu G; Fan H; Wu J; Feng J Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA SPRY4-IT1 promotes proliferation and metastasis in nasopharyngeal carcinoma cell. Li Y; Liao Z; Wang R; Liang Z; Lin Z; Deng S; Chen L; Liu Z; Feng S PeerJ; 2022; 10():e13221. PubMed ID: 35378932 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. Liu H; Lv Z; Guo E Int J Clin Exp Pathol; 2015; 8(8):9140-6. PubMed ID: 26464658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]